Sellas net loss widens 45,51% to $ 9,61 juta in Q2 FY26

Reuters2026/08/11 20:03

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Sellas Life Sciences membukukan rugi bersih USD 9,61 juta pada kuartal yang berakhir 30 Juni 2026, melebar 45,51%.
Beban operasional naik 54,66% menjadi USD 10,63 juta, dipicu R&D yang meningkat 62,02% ke USD 6,27 juta.
Pendapatan non-operasional naik menjadi USD 1,02 juta dari USD 272.000, didorong pendapatan bunga dari kas dan setara kas.
Kas dan setara kas per 30 Juni 2026 tercatat USD 138,3 juta; arus kas operasi tetap minus USD 16,43 juta.
REGAL Phase 3 GPS menunggu analisis akhir pada 80 kematian; pooled events 78 per 11 Mei 2026, masih buta data.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sellas Life Sciences Group Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001390478-26-000012), on August 11, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Sellas net loss widens 45,51% to $ 9,61 juta in Q2 FY26

You may also like

Crypto prices